Saint Vincent and the Grenadines

Last Updated 20 October 2021.

5 Vaccines Approved for Use in Saint Vincent and the Grenadines

• Moderna
  mRNA-1273

  • Phase 1
  • Phase 2
  • Phase 3
  • Approved

  This vaccine is approved.

  Approved in 76 countries

  31 trials in 2 countries

  Approval Source: health.gov.vc

  RNA

• Pfizer/BioNTech
  BNT162b2

  • Phase 1
  • Phase 2
  • Phase 3
  • Approved

  This vaccine is approved.

  Approved in 103 countries

  37 trials in 2 countries

  Approval Source: health.gov.vc

  RNA

• Gamaleya
  Sputnik V

  • Phase 1
  • Phase 2
  • Phase 3
  • Approved

  This vaccine is approved.

  Approved in 72 countries

  22 trials in 2 countries

  Approval Source: tass.com

  Non Replicating Viral Vector

• Janssen (Johnson & Johnson)
  Ad26.COV2.S

  • Phase 1
  • Phase 2
  • Phase 3
  • Approved

  This vaccine is approved.

  Approved in 75 countries

  13 trials in 16 countries

  Approval Source: health.gov.vc

  Non Replicating Viral Vector

• Serum Institute of India
  Covishield (Oxford/AstraZeneca formulation)

  • Phase 1
  • Phase 2
  • Phase 3
  • Approved

  This vaccine is approved.

  Approved in 46 countries

  2 trials in 1 country

  Approval Source: loopnewscaribbean.com

  Non Replicating Viral Vector

0 Vaccines in Clinical Trials in Saint Vincent and the Grenadines